A Gene Editing Therapy Cut Cholesterol Levels by Half
An experimental gene-editing therapy developed by Crispr Therapeutics is showing promise for treating heart disease.
8 Nov 14:56 · WIRED
Harmful cholesterol levels cut in half with one-time gene editing drug in early trial
One dose of an experimental drug cover offer lifetime treatment for people with high cholesterol, but its long-term safety is uncertain.
8 Nov 18:42 · 5 NBCDFW
last updated on 9 Nov 00:57